These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8143774)

  • 1. Interphase AgNOR quantity is not related to DNA content in 11 established human cancer cell lines.
    Derenzini M; Trerè D; Chieco P; Melchiorri C
    Exp Cell Res; 1994 Apr; 211(2):282-5. PubMed ID: 8143774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interphase AgNOR quantity and DNA content in endometrial adenocarcinoma.
    Trerè D; Melchiorri C; Chieco P; Marabini A; Derenzini M
    Gynecol Oncol; 1994 May; 53(2):202-7. PubMed ID: 8188080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AgNOR proteins as a parameter of the rapidity of cell proliferation.
    Derenzini M; Trerè D
    Zentralbl Pathol; 1994 Mar; 140(1):7-10. PubMed ID: 7515676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The quantity of nucleolar proteins nucleolin and protein B23 is related to cell doubling time in human cancer cells.
    Derenzini M; Sirri V; Trerè D; Ochs RL
    Lab Invest; 1995 Oct; 73(4):497-502. PubMed ID: 7474921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo bromodeoxyuridine labelling index, AgNOR protein expression and DNA content in human tumours.
    Trerè D; Ceccarelli C; Danova M; Derenzini M
    Eur J Histochem; 1996; 40(1):17-26. PubMed ID: 8741096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p120 expression provides a reliable indication of the rapidity of cell duplication in cancer cells independently of tumour origin.
    Trerè D; Migaldi M; Montanaro L; Pession A; Derenzini M
    J Pathol; 2000 Oct; 192(2):216-20. PubMed ID: 11004698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-myc amplification and cell proliferation rate in human neuroblastoma.
    Pession A; Trerè D; Perri P; Rondelli R; Montanaro L; Mantovani W; Derenzini M; Paolucci G
    J Pathol; 1997 Nov; 183(3):339-44. PubMed ID: 9422991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher reproducibility of morphometric analysis over the counting method for interphase AgNOR quantification.
    Trerè D; Migaldi M; Trentini GP
    Anal Cell Pathol; 1995 Jan; 8(1):57-65. PubMed ID: 7734412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of DNA ploidy pattern and nucleolar organizer regions (AgNOR) in colorectal carcinoma.
    Eminović-Behrem S; Trobonjaca Z; Petrovecki M; Dobi-Babić R; Dujmović M; Jonjić N
    Croat Med J; 2000 Jun; 41(2):154-8. PubMed ID: 10853043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of three-dimensional distribution of AgNOR proteins during interphase in leukemic cells.
    Wozniak ZM; Usson Y; Parazza F; Champelovier P; Leroux D; Seigneurin D
    Cytometry; 1996 May; 24(1):14-26. PubMed ID: 8723898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silver-stained nucleolar organizer regions in normal and dysplastic cervical lesions: correlation with DNA ploidy and S-phase fraction by flow cytometry.
    Singh M; Prasad S; Kalra N; Singh U; Shukla Y
    Oncology; 2006; 71(5-6):411-6. PubMed ID: 17785995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AgNOR quantification with special reference to staining patterns.
    Rüschoff J; Fauser G; Knüchel R; Hofstädter F
    Zentralbl Pathol; 1994 Mar; 140(1):23-30. PubMed ID: 7515669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of DNA ploidy and proliferation rate in lung tumours by bromodeoxyuridine labelling index, S-phase fraction and AgNOR technique.
    Gasińska A; Biesaga B; Kołodziejski L; Słonina D
    Pol J Pathol; 1996; 47(4):201-7. PubMed ID: 9097713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interphase nucleolar organizer regions in the evaluation of serosal cavity effusions.
    Carrillo R; Sneige N; el-Naggar AK
    Acta Cytol; 1994; 38(3):367-72. PubMed ID: 8191825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantity of nucleolar silver-stained proteins is related to proliferating activity in cancer cells.
    Derenzini M; Pession A; Trerè D
    Lab Invest; 1990 Jul; 63(1):137-40. PubMed ID: 1695695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between AgNORs, MIB-1 and oncogene expression in male breast carcinoma and papillary superficial bladder neoplasm.
    Pich A; Margaria E; Chiusa L; Bortolin P; Palestro G
    Oncol Rep; 2003; 10(5):1329-35. PubMed ID: 12883702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AgNOR area in interphase nuclei of human tumours correlates with the proliferative activity evaluated by bromodeoxyuridine labelling and Ki-67 immunostaining.
    Trerè D; Farabegoli F; Cancellieri A; Ceccarelli C; Eusebi V; Derenzini M
    J Pathol; 1991 Sep; 165(1):53-9. PubMed ID: 1955936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of the AgNOR in tumor pathology].
    Pich A; Margaria E; Chiusa L
    Pathologica; 2002 Feb; 94(1):2-9. PubMed ID: 11912874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The study of AgNOR proteins in leukemias: diagnostic value and correlation to S-phase cell fraction.
    Klobusická M; Babusíková O; Mesárosová A; Kusenda J; Glasová M
    Neoplasma; 1996; 43(6):397-401. PubMed ID: 8996564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The AgNOR proteins: qualitative and quantitative changes during the cell cycle.
    Sirri V; Roussel P; Hernandez-Verdun D
    Micron; 2000 Apr; 31(2):121-6. PubMed ID: 10588057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.